dc.contributor | American Society of Tropical Medicine and Hygiene | |
dc.creator | Silva, Flavia Alessandra de Souza | |
dc.creator | Sanchez, Bruno Antonio Marinho | |
dc.creator | Cerávolo, Isabela Penna | |
dc.creator | Brito, Cristiana Ferreira Alves de | |
dc.creator | Carvalho, Luzia Helena de | |
dc.creator | Nunes, Mônica da Silva | |
dc.creator | Ferreira, Marcelo Urbano | |
dc.creator | Malafronte, Rosely dos Santos | |
dc.date | 2013-10-03T16:08:12Z | |
dc.date | 2013-10-03T16:08:12Z | |
dc.date | 2010 | |
dc.date.accessioned | 2023-09-27T00:10:45Z | |
dc.date.available | 2023-09-27T00:10:45Z | |
dc.identifier | SOUZA SILVA, Flávia A et al. Naturally Acquired Antibodies to Plasmodium vivax Duffy Binding Protein (DBP) in Rural Brazilian Amazon. Am J Trop Med Hyg. 2010 February; 82(2): 185–193. | |
dc.identifier | 0002-9637 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/7078 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8898234 | |
dc.description | Duffy binding protein (DBP), a leading malaria vaccine candidate, plays a critical role in Plasmodium vivax erythrocyte invasion. Sixty-eight of 366 (18.6%) subjects had IgG anti-DBP antibodies by enzyme-linked immunosor bent assay (ELISA) in a community-based cross-sectional survey in the Brazilian Amazon Basin. Despite continuous exposure to low-level malaria transmission, the overall seroprevalence decreased to 9.0% when the population was reexamined 12 months later. Antibodies from 16 of 50 (36.0%) subjects who were ELISA-positive at the baseline were able to inhibit erythrocyte binding to at least one of two DBP variants tested. Most (13 of 16) of these subjects still had inhibitory anti-bodies when reevaluated 12 months later. Cumulative exposure to malaria was the strongest predictor of DBP seroposi-tivity identified by multiple logistic regression models in this population. The poor antibody recognition of DBP elicited by natural exposure to P. vivaxin Amazonian populations represents a challenge to be addressed by vaccine development strategies. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.rights | restricted access | |
dc.subject | Duffy binding protein | |
dc.subject | malaria vaccine | |
dc.title | Naturally Acquired Antibodies to Plasmodium vivax Duffy Binding Protein (DBP) in Rural Brazilian Amazon. | |
dc.type | Article | |